Loading…
Syme Ankle Disarticulation in Patients with Diabetes
BackgroundSyme ankle disarticulation is an amputation level that minimizes disability and preserves function, but it has been used sparingly in patients with diabetes mellitus. Surgeons have avoided this level because of the perceived high risk for wound failure, wound infection, or migration of the...
Saved in:
Published in: | Journal of bone and joint surgery. American volume 2003-09, Vol.85 (9), p.1667-1672 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c4133-d3833c4e032676e9e08299382bc50f5a010b723c69d17602e80361649c063c923 |
---|---|
cites | cdi_FETCH-LOGICAL-c4133-d3833c4e032676e9e08299382bc50f5a010b723c69d17602e80361649c063c923 |
container_end_page | 1672 |
container_issue | 9 |
container_start_page | 1667 |
container_title | Journal of bone and joint surgery. American volume |
container_volume | 85 |
creator | Pinzur, Michael S Stuck, Rodney M Sage, Ronald Hunt, Nathan Rabinovich, Zinoviy |
description | BackgroundSyme ankle disarticulation is an amputation level that minimizes disability and preserves function, but it has been used sparingly in patients with diabetes mellitus. Surgeons have avoided this level because of the perceived high risk for wound failure, wound infection, or migration of the heel pad, which makes prosthesis use difficult.MethodsNinety-seven adult patients with diabetes mellitus who underwent Syme ankle disarticulation because of a neuropathic foot with an infection or gangrene, or both, during an eleven-year period were studied retrospectively. Selection of the amputation level was made on the basis of clinical examination and an assessment of the wound-healing parameters, i.e., vascular inflow, tissue nutrition, and immunocompetence. The average age of the patients was 53.2 ± 17.5 years.ResultsEighty-two patients (84.5%) ultimately achieved wound-healing. When threshold levels for vascular inflow (ultrasound Doppler ischemic index of 0.5 or transcutaneous partial pressure of oxygen between 20 and 30 mm Hg) and tissue nutrition (serum albumin of 2.5 g/dL) were met, an overall success rate of 88% was achieved. Total lymphocyte count (an absolute lymphocyte count of 1500) and the smoking of cigarettes during the study period did not appear to impact wound-healing rates. The overall infection rate was 23%, and it was three times greater in smokers. Most infections were managed with local wound care and antibiotic therapy. At a minimum follow-up of two years, all but two patients were able to walk with a prosthesis. Thirty of the ninety-seven patients died at an average of 57.1 months following surgery.ConclusionsThe results of this retrospective review support the value of Syme ankle disarticulation in diabetic patients with infection or gangrene. This function-sparing amputation can be successfully performed with a reasonable risk. Patients managed with a Syme ankle disarticulation appeared to remain able to walk better and to survive longer than similar patients who had a transtibial amputation and served as historical controls. In diabetic patients with dysvascular disease who have adequate vascular inflow to support wound-healing (an ultrasound Doppler ischemic index of 0.5 or a transcutaneous partial pressure of oxygen between 20 and 30 mm Hg), the threshold for the wound-healing parameter of serum albumin appears to be as low as 2.5 g/dL.Level of EvidenceTherapeutic study, Level IV (case series [no, or historical, control group] |
doi_str_mv | 10.2106/00004623-200309000-00003 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73633608</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>73633608</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4133-d3833c4e032676e9e08299382bc50f5a010b723c69d17602e80361649c063c923</originalsourceid><addsrcrecordid>eNp1kdFLHDEQxoNY9Dz9F2QR9G3bSSbJJo-i1haEFqrPIZeb41Zzu5rscvjfN9c7FYTOSybD7_uYfGGs4vBVcNDfoJTUAmsBgGDLrd6McI9NuEJVczR6n00ABK8tKnXIjnJ-3IgkNAfskAurpBE4YfLP64qqy-4pUnXdZp-GNozRD23fVW1X_S4ddUOu1u2wLICf0UD5mH1Z-JjpZHdO2cP3m_urH_Xdr9ufV5d3dZAcsZ6jQQySAIVuNFkCI6xFI2ZBwUJ54DBrBAZt57zRIMgAaq6lDaAxWIFTdrH1fU79y0h5cKs2B4rRd9SP2TWoETWYAp59Ah_7MXVlNydAcVBGqgKZLRRSn3OihXtO7cqnV8fBbWJ1b7G691j_jbBIT3f-42xF8w_hLscCnO8An4OPi-S70OYPTnGNUF41ZXLLrfs4UMpPcVxTckvycVi6_30r_gV1jYqv</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>205105845</pqid></control><display><type>article</type><title>Syme Ankle Disarticulation in Patients with Diabetes</title><source>HEAL-Link subscriptions: Lippincott Williams & Wilkins</source><creator>Pinzur, Michael S ; Stuck, Rodney M ; Sage, Ronald ; Hunt, Nathan ; Rabinovich, Zinoviy</creator><creatorcontrib>Pinzur, Michael S ; Stuck, Rodney M ; Sage, Ronald ; Hunt, Nathan ; Rabinovich, Zinoviy</creatorcontrib><description>BackgroundSyme ankle disarticulation is an amputation level that minimizes disability and preserves function, but it has been used sparingly in patients with diabetes mellitus. Surgeons have avoided this level because of the perceived high risk for wound failure, wound infection, or migration of the heel pad, which makes prosthesis use difficult.MethodsNinety-seven adult patients with diabetes mellitus who underwent Syme ankle disarticulation because of a neuropathic foot with an infection or gangrene, or both, during an eleven-year period were studied retrospectively. Selection of the amputation level was made on the basis of clinical examination and an assessment of the wound-healing parameters, i.e., vascular inflow, tissue nutrition, and immunocompetence. The average age of the patients was 53.2 ± 17.5 years.ResultsEighty-two patients (84.5%) ultimately achieved wound-healing. When threshold levels for vascular inflow (ultrasound Doppler ischemic index of 0.5 or transcutaneous partial pressure of oxygen between 20 and 30 mm Hg) and tissue nutrition (serum albumin of 2.5 g/dL) were met, an overall success rate of 88% was achieved. Total lymphocyte count (an absolute lymphocyte count of 1500) and the smoking of cigarettes during the study period did not appear to impact wound-healing rates. The overall infection rate was 23%, and it was three times greater in smokers. Most infections were managed with local wound care and antibiotic therapy. At a minimum follow-up of two years, all but two patients were able to walk with a prosthesis. Thirty of the ninety-seven patients died at an average of 57.1 months following surgery.ConclusionsThe results of this retrospective review support the value of Syme ankle disarticulation in diabetic patients with infection or gangrene. This function-sparing amputation can be successfully performed with a reasonable risk. Patients managed with a Syme ankle disarticulation appeared to remain able to walk better and to survive longer than similar patients who had a transtibial amputation and served as historical controls. In diabetic patients with dysvascular disease who have adequate vascular inflow to support wound-healing (an ultrasound Doppler ischemic index of 0.5 or a transcutaneous partial pressure of oxygen between 20 and 30 mm Hg), the threshold for the wound-healing parameter of serum albumin appears to be as low as 2.5 g/dL.Level of EvidenceTherapeutic study, Level IV (case series [no, or historical, control group]). See Instructions to Authors for a complete description of levels of evidence.</description><edition>American volume</edition><identifier>ISSN: 0021-9355</identifier><identifier>EISSN: 1535-1386</identifier><identifier>DOI: 10.2106/00004623-200309000-00003</identifier><identifier>PMID: 12954823</identifier><identifier>CODEN: JBJSA3</identifier><language>eng</language><publisher>Boston, MA: Copyright by The Journal of Bone and Joint Surgery, Incorporated</publisher><subject>Amputation - methods ; Ankle Joint - surgery ; Biological and medical sciences ; Chi-Square Distribution ; Diabetic Foot - surgery ; Female ; Humans ; Male ; Medical sciences ; Middle Aged ; Orthopedic surgery ; Retrospective Studies ; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases ; Treatment Outcome ; Wound Healing</subject><ispartof>Journal of bone and joint surgery. American volume, 2003-09, Vol.85 (9), p.1667-1672</ispartof><rights>Copyright 2003 by The Journal of Bone and Joint Surgery, Incorporated</rights><rights>2004 INIST-CNRS</rights><rights>Copyright Journal of Bone and Joint Surgery, Inc. Sep 2003</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4133-d3833c4e032676e9e08299382bc50f5a010b723c69d17602e80361649c063c923</citedby><cites>FETCH-LOGICAL-c4133-d3833c4e032676e9e08299382bc50f5a010b723c69d17602e80361649c063c923</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=15163006$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12954823$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pinzur, Michael S</creatorcontrib><creatorcontrib>Stuck, Rodney M</creatorcontrib><creatorcontrib>Sage, Ronald</creatorcontrib><creatorcontrib>Hunt, Nathan</creatorcontrib><creatorcontrib>Rabinovich, Zinoviy</creatorcontrib><title>Syme Ankle Disarticulation in Patients with Diabetes</title><title>Journal of bone and joint surgery. American volume</title><addtitle>J Bone Joint Surg Am</addtitle><description>BackgroundSyme ankle disarticulation is an amputation level that minimizes disability and preserves function, but it has been used sparingly in patients with diabetes mellitus. Surgeons have avoided this level because of the perceived high risk for wound failure, wound infection, or migration of the heel pad, which makes prosthesis use difficult.MethodsNinety-seven adult patients with diabetes mellitus who underwent Syme ankle disarticulation because of a neuropathic foot with an infection or gangrene, or both, during an eleven-year period were studied retrospectively. Selection of the amputation level was made on the basis of clinical examination and an assessment of the wound-healing parameters, i.e., vascular inflow, tissue nutrition, and immunocompetence. The average age of the patients was 53.2 ± 17.5 years.ResultsEighty-two patients (84.5%) ultimately achieved wound-healing. When threshold levels for vascular inflow (ultrasound Doppler ischemic index of 0.5 or transcutaneous partial pressure of oxygen between 20 and 30 mm Hg) and tissue nutrition (serum albumin of 2.5 g/dL) were met, an overall success rate of 88% was achieved. Total lymphocyte count (an absolute lymphocyte count of 1500) and the smoking of cigarettes during the study period did not appear to impact wound-healing rates. The overall infection rate was 23%, and it was three times greater in smokers. Most infections were managed with local wound care and antibiotic therapy. At a minimum follow-up of two years, all but two patients were able to walk with a prosthesis. Thirty of the ninety-seven patients died at an average of 57.1 months following surgery.ConclusionsThe results of this retrospective review support the value of Syme ankle disarticulation in diabetic patients with infection or gangrene. This function-sparing amputation can be successfully performed with a reasonable risk. Patients managed with a Syme ankle disarticulation appeared to remain able to walk better and to survive longer than similar patients who had a transtibial amputation and served as historical controls. In diabetic patients with dysvascular disease who have adequate vascular inflow to support wound-healing (an ultrasound Doppler ischemic index of 0.5 or a transcutaneous partial pressure of oxygen between 20 and 30 mm Hg), the threshold for the wound-healing parameter of serum albumin appears to be as low as 2.5 g/dL.Level of EvidenceTherapeutic study, Level IV (case series [no, or historical, control group]). See Instructions to Authors for a complete description of levels of evidence.</description><subject>Amputation - methods</subject><subject>Ankle Joint - surgery</subject><subject>Biological and medical sciences</subject><subject>Chi-Square Distribution</subject><subject>Diabetic Foot - surgery</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Orthopedic surgery</subject><subject>Retrospective Studies</subject><subject>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</subject><subject>Treatment Outcome</subject><subject>Wound Healing</subject><issn>0021-9355</issn><issn>1535-1386</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><recordid>eNp1kdFLHDEQxoNY9Dz9F2QR9G3bSSbJJo-i1haEFqrPIZeb41Zzu5rscvjfN9c7FYTOSybD7_uYfGGs4vBVcNDfoJTUAmsBgGDLrd6McI9NuEJVczR6n00ABK8tKnXIjnJ-3IgkNAfskAurpBE4YfLP64qqy-4pUnXdZp-GNozRD23fVW1X_S4ddUOu1u2wLICf0UD5mH1Z-JjpZHdO2cP3m_urH_Xdr9ufV5d3dZAcsZ6jQQySAIVuNFkCI6xFI2ZBwUJ54DBrBAZt57zRIMgAaq6lDaAxWIFTdrH1fU79y0h5cKs2B4rRd9SP2TWoETWYAp59Ah_7MXVlNydAcVBGqgKZLRRSn3OihXtO7cqnV8fBbWJ1b7G691j_jbBIT3f-42xF8w_hLscCnO8An4OPi-S70OYPTnGNUF41ZXLLrfs4UMpPcVxTckvycVi6_30r_gV1jYqv</recordid><startdate>200309</startdate><enddate>200309</enddate><creator>Pinzur, Michael S</creator><creator>Stuck, Rodney M</creator><creator>Sage, Ronald</creator><creator>Hunt, Nathan</creator><creator>Rabinovich, Zinoviy</creator><general>Copyright by The Journal of Bone and Joint Surgery, Incorporated</general><general>Journal of Bone and Joint Surgery Incorporated</general><general>Journal of Bone and Joint Surgery AMERICAN VOLUME</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7QO</scope><scope>7QP</scope><scope>7RV</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>200309</creationdate><title>Syme Ankle Disarticulation in Patients with Diabetes</title><author>Pinzur, Michael S ; Stuck, Rodney M ; Sage, Ronald ; Hunt, Nathan ; Rabinovich, Zinoviy</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4133-d3833c4e032676e9e08299382bc50f5a010b723c69d17602e80361649c063c923</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Amputation - methods</topic><topic>Ankle Joint - surgery</topic><topic>Biological and medical sciences</topic><topic>Chi-Square Distribution</topic><topic>Diabetic Foot - surgery</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Orthopedic surgery</topic><topic>Retrospective Studies</topic><topic>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</topic><topic>Treatment Outcome</topic><topic>Wound Healing</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pinzur, Michael S</creatorcontrib><creatorcontrib>Stuck, Rodney M</creatorcontrib><creatorcontrib>Sage, Ronald</creatorcontrib><creatorcontrib>Hunt, Nathan</creatorcontrib><creatorcontrib>Rabinovich, Zinoviy</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>ProQuest Nursing & Allied Health Database</collection><collection>Virology and AIDS Abstracts</collection><collection>ProQuest Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Science Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of bone and joint surgery. American volume</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pinzur, Michael S</au><au>Stuck, Rodney M</au><au>Sage, Ronald</au><au>Hunt, Nathan</au><au>Rabinovich, Zinoviy</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Syme Ankle Disarticulation in Patients with Diabetes</atitle><jtitle>Journal of bone and joint surgery. American volume</jtitle><addtitle>J Bone Joint Surg Am</addtitle><date>2003-09</date><risdate>2003</risdate><volume>85</volume><issue>9</issue><spage>1667</spage><epage>1672</epage><pages>1667-1672</pages><issn>0021-9355</issn><eissn>1535-1386</eissn><coden>JBJSA3</coden><abstract>BackgroundSyme ankle disarticulation is an amputation level that minimizes disability and preserves function, but it has been used sparingly in patients with diabetes mellitus. Surgeons have avoided this level because of the perceived high risk for wound failure, wound infection, or migration of the heel pad, which makes prosthesis use difficult.MethodsNinety-seven adult patients with diabetes mellitus who underwent Syme ankle disarticulation because of a neuropathic foot with an infection or gangrene, or both, during an eleven-year period were studied retrospectively. Selection of the amputation level was made on the basis of clinical examination and an assessment of the wound-healing parameters, i.e., vascular inflow, tissue nutrition, and immunocompetence. The average age of the patients was 53.2 ± 17.5 years.ResultsEighty-two patients (84.5%) ultimately achieved wound-healing. When threshold levels for vascular inflow (ultrasound Doppler ischemic index of 0.5 or transcutaneous partial pressure of oxygen between 20 and 30 mm Hg) and tissue nutrition (serum albumin of 2.5 g/dL) were met, an overall success rate of 88% was achieved. Total lymphocyte count (an absolute lymphocyte count of 1500) and the smoking of cigarettes during the study period did not appear to impact wound-healing rates. The overall infection rate was 23%, and it was three times greater in smokers. Most infections were managed with local wound care and antibiotic therapy. At a minimum follow-up of two years, all but two patients were able to walk with a prosthesis. Thirty of the ninety-seven patients died at an average of 57.1 months following surgery.ConclusionsThe results of this retrospective review support the value of Syme ankle disarticulation in diabetic patients with infection or gangrene. This function-sparing amputation can be successfully performed with a reasonable risk. Patients managed with a Syme ankle disarticulation appeared to remain able to walk better and to survive longer than similar patients who had a transtibial amputation and served as historical controls. In diabetic patients with dysvascular disease who have adequate vascular inflow to support wound-healing (an ultrasound Doppler ischemic index of 0.5 or a transcutaneous partial pressure of oxygen between 20 and 30 mm Hg), the threshold for the wound-healing parameter of serum albumin appears to be as low as 2.5 g/dL.Level of EvidenceTherapeutic study, Level IV (case series [no, or historical, control group]). See Instructions to Authors for a complete description of levels of evidence.</abstract><cop>Boston, MA</cop><pub>Copyright by The Journal of Bone and Joint Surgery, Incorporated</pub><pmid>12954823</pmid><doi>10.2106/00004623-200309000-00003</doi><tpages>6</tpages><edition>American volume</edition></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0021-9355 |
ispartof | Journal of bone and joint surgery. American volume, 2003-09, Vol.85 (9), p.1667-1672 |
issn | 0021-9355 1535-1386 |
language | eng |
recordid | cdi_proquest_miscellaneous_73633608 |
source | HEAL-Link subscriptions: Lippincott Williams & Wilkins |
subjects | Amputation - methods Ankle Joint - surgery Biological and medical sciences Chi-Square Distribution Diabetic Foot - surgery Female Humans Male Medical sciences Middle Aged Orthopedic surgery Retrospective Studies Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases Treatment Outcome Wound Healing |
title | Syme Ankle Disarticulation in Patients with Diabetes |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T17%3A51%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Syme%20Ankle%20Disarticulation%20in%20Patients%20with%20Diabetes&rft.jtitle=Journal%20of%20bone%20and%20joint%20surgery.%20American%20volume&rft.au=Pinzur,%20Michael%20S&rft.date=2003-09&rft.volume=85&rft.issue=9&rft.spage=1667&rft.epage=1672&rft.pages=1667-1672&rft.issn=0021-9355&rft.eissn=1535-1386&rft.coden=JBJSA3&rft_id=info:doi/10.2106/00004623-200309000-00003&rft_dat=%3Cproquest_cross%3E73633608%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4133-d3833c4e032676e9e08299382bc50f5a010b723c69d17602e80361649c063c923%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=205105845&rft_id=info:pmid/12954823&rfr_iscdi=true |